CRANBURY, N.J.--(BUSINESS WIRE)--Pharmaceutical Executive®, a multimedia platform for industry leaders to exchange experiences and insights about innovative business and marketing ideas, is pleased to announce that nominations are now being accepted for the 2021 Emerging Pharma Leaders awards recognition program, until February 26, 2021.
“Recognizing rising executives in the pharma and biotech industries who are dedicated to improving the lives of patients is something we look forward to each year,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, the parent company of Pharmaceutical Executive®. “We are continuously amazed by the nominations we have received year after year and look forward to celebrating the next class of exceptional emerging leaders in May.”
The Emerging Pharma Leaders awards recognition program was established in 2008 to recognize a select group of industry executives whose peers and supervisors believe will change the future of the pharma industry. All eligible nominees employed by pharmaceutical or biotech companies will be judged by three Pharmaceutical Executive® editorial advisory board members and a former Emerging Pharma Leader representative.
This year’s class of inductees will be honored in a webcast on May 11. Additionally, each winner will be featured on the cover and inside the Pharmaceutical Executive® May 2021 issue.
For more information and to submit a nomination, click here.
About Pharmaceutical Executive®
Pharmaceutical Executive® is a multimedia platform that offers news, opinions, analysis, features and executive profiles. The magazine and its website serve as a forum for industry leaders to exchange opinions, experiences and insights about innovative business and marketing ideas, strategies and tactics. Pharmaceutical Executive® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.
